HIV-1 clade C escapes broadly neutralizing autologous antibodies with N332 glycan specificity by distinct mechanisms

Overview of attention for article published in Retrovirology, August 2016

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (72nd percentile)
Good Attention Score compared to outputs of the same age and source (79th percentile)

Mentioned by

twitter: 4 X users

patent: 2 patents

Readers on

mendeley: 32 Mendeley

Summary X Patents

So far, Altmetric has seen 2 patents that reference this research output.

Antibody therapies for human immunodeficiency virus (HIV)

Grant US-11845788-B2

United States of America

Human immunodeficiency virus therapies utilizing N332-glycan-dependent antibodies in…

Grant US-11202830-B2

United States of America

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.